Publications Database

Almeida D. M. et al. (2013)

Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report.

Pancreas

January, 42(1), pp. 177-118.

Read Abstract (New Window)

Camacho A. et al. (2012)

Levetiracetam-induced reversible autistic regression.

Pediatric Neurology

47(1), pp. 65-67.

Read Abstract (New Window)

Canitano R. (2015)

Mood stabilizers in children and adolescents with autism spectrum disorders.

Clinical Neuropharmacology

September, 38(5), pp. 177-182.

Read Abstract (New Window)

Deriaz N. et al. (2012)

Treatment with levetiracetam in a patient with pervasive developmental disorders, severe intellectual disability, self-injurious behavior, and seizures: A case report.

Neurocase

18(5), pp. 386-391.

Read Abstract (New Window)

Doyle C. A. , McDougle C. J. (2012)

Pharmacotherapy to control behavioral symptoms in children with autism.

Expert Opinion on Pharmacotherapy

13(11), pp. 1615-1629.

Read Abstract (New Window)

Frye R. E. et al. (2013)

A review of traditional and novel treatments for seizures in autism spectrum disorder: Findings from a systematic review and expert panel.

Frontiers in Public Health

Read Abstract (New Window) Read Full (New Window)

Hirota T. et al. (2014)

Antiepileptic medications in autism spectrum disorder: A systematic review and meta-analysis.

Journal of Autism and Developmental Disorders

44(4), pp. 948-957.

Read Abstract (New Window)

Jiang L. , Wang M. , Tang X. (2017)

Levetiracetam is associated with decrease in subclinical epileptiform discharges and improved cognitive functions in pediatric patients with autism spectrum disorder.

Neuropsychiatric Disease and Treatment

13 pp. 2321–2326.

Read Abstract (New Window) Read Full (New Window)

Larsson P. G. et al. (2012)

The effect of levetiracetam on focal nocturnal epileptiform activity during sleep: A placebo-controlled double-blind cross-over study.

Epilepsy and Behavior

24(1), pp. 44-48.

Read Abstract (New Window)

Morrow J. et al. (2006)

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register.

Journal of Neurology and Neurosurgical Psychiatry

February, 77(2), pp. 193-198

Read Abstract (New Window) Read Full (New Window)

American Society of Health-System Pharmacists (2008)

Levetiracetam.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Rajapakse T. , Pringsheim T. (2010)

Pharmacotherapeutics of tourette syndrome and stereotypies in autism.

Seminars in Pediatric Neurology

17(4), pp. 254-260

Read Abstract (New Window)

Rugino T. A. , Samsock T. C. (2002)

Levetiracetam in autistic children: an open-label study.

Journal of Developmental and Behavioral Pediatrics

23(4), pp. 225-230

Read Abstract (New Window)

Stigler K. A. , McDougle C. J. (2008)

Pharmacotherapy of irritability in pervasive developmental disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 739-752

Read Abstract (New Window)

Wasserman S. et al. (2006)

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

International Clinical Psychopharmacology

21(6), pp. 363-367

Read Abstract (New Window)